Home › Research › Biomarkers
Dream recall in cognitively healthy older adults: associations with blood p ‐tau217 levels, APOE ε4 carriage, and cognitive decline
Darren M. Lipnicki, Meritxell Valenti, Elizabeth Valeriano-Lorenzo, Ashleigh S. Vella, María Ascensión Zea‐Sevilla, Mario Emiliano Ricciardi, Belén Frades, Minerva Martinez et al.. Alzheimer s & Dementia, 2025-12-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Abstract Background Evidence suggests that dreaming is subserved by the default mode network (DMN) (Domhoff, 2022. Given this, we reasoned that dream recall in cognitively normal older adults may be associated with blood p ‐tau levels, APOE ε4 carriage, and future cognitive decline. Result Thirty‐one percent of participants did not remember dreams. Higher p ‐tau217 levels and APOE ε4 carriage were both associated with a lower likelihood of remembering dreams (OR=0.52, 95%CI=0.35‐0.79, p = .002 and OR=0.61, 95%CI=0.43‐0.86, p = .006, respectively), independently of memory test scores. Further, individuals who did not remember dreams at baseline showed faster decline in PACCm scores (β non‐DR =‐0.03) over 10 years than dream recallers (β DR =‐0.02; β Age*Dream Recall =0.011, SE=0.005, p = .036), despite dream recall status not being associated with relatively low cognition at baseline (OR=0.94, 95%CI=0‐60‐1.48, p = .788). Conclusion Dream recall status was associated with blood p ‐tau217 levels, APOE ε4 carriage, and future cognitive decline among older individuals cognitively healthy at baseline.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study. In cognitively healthy older adults, higher blood p-tau217 and APOE ε4 carriage were each associated with a lower likelihood of remembering dreams, and non-dream-recallers showed faster cognitive decline over 10 years. Reported effect size: OR=0.52; OR=0.61; OR=0.94.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Lipnicki, D. M., Valenti, M., Valeriano-Lorenzo, E., Vella, A. S., Zea‐Sevilla, M. A., Ricciardi, M. E., et al. (2025). Dream recall in cognitively healthy older adults: associations with blood p ‐tau217 levels, APOE ε4 carriage, and cognitive decline. Alzheimer s & Dementia. https://doi.org/10.1002/alz70857_097922
Vancouver
Lipnicki DM, Valenti M, Valeriano-Lorenzo E, Vella AS, Zea‐Sevilla MA, Ricciardi ME, et al. Dream recall in cognitively healthy older adults: associations with blood p ‐tau217 levels, APOE ε4 carriage, and cognitive decline. Alzheimer s & Dementia. 2025. doi:10.1002/alz70857_097922. PMID: 41444446.
BibTeX
@article{lipnicki2025-41444446,
author = {Lipnicki, Darren M. and Valenti, Meritxell and Valeriano-Lorenzo, Elizabeth and Vella, Ashleigh S. and Zea‐Sevilla, María Ascensión and Ricciardi, Mario Emiliano and Frades, Belén and Martinez, Minerva and others},
title = {{Dream recall in cognitively healthy older adults: associations with blood p ‐tau217 levels, APOE ε4 carriage, and cognitive decline}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70857_097922},
pmid = {41444446},
url = {https://doi.org/10.1002/alz70857_097922}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Abstract Background Evidence suggests that dreaming is subserved by the default mode network (DMN) (Domhoff, 2022.
- Given this, we reasoned that dream recall in cognitively normal older adults may be associated with blood p ‐tau levels, APOE ε4 carriage, and future cognitive decline.
- Result Thirty‐one percent of participants did not remember dreams.
- Higher p ‐tau217 levels and APOE ε4 carriage were both associated with a lower likelihood of remembering dreams (OR=0.52, 95%CI=0.35‐0.79, p = .002 and OR=0.61, 95%CI=0.43‐0.86, p = .006, respectively), independently of memory test scores.
- Further, individuals who did not remember dreams at baseline showed faster decline in PACCm scores (β non‐DR =‐0.03) over 10 years than dream recallers (β DR =‐0.02; β Age*Dream Recall =0.011, SE=0.005, p = .036), despite dream recall status not being associated with relatively low cognition at baseline (OR=0.94, 95%CI=0‐60‐1.48, p = .788).
Why it matters
In cognitively healthy older adults, higher blood p-tau217 and APOE ε4 carriage were each associated with a lower likelihood of remembering dreams, and non-dream-recallers showed faster cognitive decline over 10 years. This is an observational association and does not show that dream recall affects the disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Study designlongitudinal study
- Effect sizeOR=0.52; OR=0.61; OR=0.94
- Evidence strengthModerate
How this study scored 44/100
Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Pascual Sánchez‐Juan: h-index 17 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | UNSW Sydney: institution h-index 1,101 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41444446) |
| Free to read | 2 / 2 | Free to read |
| Total | 44 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70857_097922
- PubMed: 41444446
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.